Screening compound: InChI=1S/C15H22N6OS/c1-9(2)14(22)21-7-6-11-10(8-21)12(18-20(11)4)13-16-17-15(23-5)19(13)3/h9H,6-8H2,1-5H3

Screening compound: InChI=1S/C15H22N6OS/c1-9(2)14(22)21-7-6-11-10(8-21)12(18-20(11)4)13-16-17-15(23-5)19(13)3/h9H,6-8H2,1-5H3
Screening compound: InChI=1S/C15H22N6OS/c1-9(2)14(22)21-7-6-11-10(8-21)12(18-20(11)4)13-16-17-15(23-5)19(13)3/h9H,6-8H2,1-5H3 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C15H22N6OS/c1-9(2)14(22)21-7-6-11-10(8-21)12(18-20(11)4)13-16-17-15(23-5)19(13)3/h9H,6-8H2,1-5H3

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L886-0310

Molecular Formula

C15H22N6OS (C15 H22 N6 OS)

Compound Name

2-methyl-1-{1-methyl-3-[4-methyl-5-(methylsulfanyl)-4H-1,2,4-triazol-3-yl]-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-5-yl}propan-1-one

IUPAC name

2-methyl-1-{1-methyl-3-[4-methyl-5-(methylsulfanyl)-4H-124-triazol-3-yl]-1H4H5H6H7H-pyrazolo[43-c]pyridin-5-yl}propan-1-one

SMILES

CC(C)C(N(CC1)Cc2c1n(C)nc2-c(n1C)nnc1SC)=O

InChI

InChI=1S/C15H22N6OS/c1-9(2)14(22)21-7-6-11-10(8-21)12(18-20(11)4)13-16-17-15(23-5)19(13)3/h9H,6-8H2,1-5H3

InChI Key

KFRBALOXDFSAJA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27484184

InChI=1S/C15H22N6OS/c1-9(2)14(22)21-7-6-11-10(8-21)12(18-20(11)4)13-16-17-15(23-5)19(13)3/h9H,6-8H2,1-5H3 in Drug Discovery

Included in Screening Libraries

CNS MPO Library (28609 compounds)

Cysteine Proteases Inhibitors Library (7839 compounds)

Hsp90-Targeted Library (11355 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Ion Channels Focused Library (26372 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Cardiovascular
  • Skin
  • Metabolic
  • Endocrine
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Nervous system
  • Cardiovascular
Targets:
  • Proteases
  • Ion Channels
Mechanism of action:
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with InChI=1S/C15H22N6OS/c1-9(2)14(22)21-7-6-11-10(8-21)12(18-20(11)4)13-16-17-15(23-5)19(13)3/h9H,6-8H2,1-5H3 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C15H22N6OS/c1-9(2)14(22)21-7-6-11-10(8-21)12(18-20(11)4)13-16-17-15(23-5)19(13)3/h9H,6-8H2,1-5H3?
Check Price and Availability of InChI=1S/C15H22N6OS/c1-9(2)14(22)21-7-6-11-10(8-21)12(18-20(11)4)13-16-17-15(23-5)19(13)3/h9H,6-8H2,1-5H3, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C15H22N6OS/c1-9(2)14(22)21-7-6-11-10(8-21)12(18-20(11)4)13-16-17-15(23-5)19(13)3/h9H,6-8H2,1-5H3 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C15H22N6OS/c1-9(2)14(22)21-7-6-11-10(8-21)12(18-20(11)4)13-16-17-15(23-5)19(13)3/h9H,6-8H2,1-5H3
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C15H22N6OS/c1-9(2)14(22)21-7-6-11-10(8-21)12(18-20(11)4)13-16-17-15(23-5)19(13)3/h9H,6-8H2,1-5H3
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C15H22N6OS/c1-9(2)14(22)21-7-6-11-10(8-21)12(18-20(11)4)13-16-17-15(23-5)19(13)3/h9H,6-8H2,1-5H3 available by request